Register to chat with like-minded investors on our interactive forums.
Period:
Draw Mode:
| Volume | 75,504 |
|
|||||
| News | (1) | ||||||
| Day High | 2.80 | Low High |
|||||
| Day Low | 2.60 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| LAVA Therapeutics NV | LVTX | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| -0.05 | -1.85% | 2.65 | 18:00:04 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 2.70 | 2.60 | 2.80 | 2.65 | 2.70 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 348 | 75,504 | $ 2.69 | $ 202,895 | - | 1.131 - 6.47 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 19:01:14 | 1 | $ 2.88 | USD |
LAVA Therapeutics NV Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 69.67M | 26.29M | - | 6.77M | -41.97M | -1.60 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
LAVA Therapeutics NV News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical LVTX Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 3.00 | 3.00 | 2.56 | 2.80 | 62,636 | -0.35 | -11.67% |
| 1 Month | 2.93 | 3.20 | 2.52 | 2.88 | 83,867 | -0.28 | -9.56% |
| 3 Months | 2.05 | 6.47 | 2.02 | 3.05 | 1,145,771 | 0.60 | 29.27% |
| 6 Months | 1.50 | 6.47 | 1.35 | 2.68 | 946,688 | 1.15 | 76.67% |
| 1 Year | 1.80 | 6.47 | 1.131 | 2.62 | 641,441 | 0.85 | 47.22% |
| 3 Years | 12.03 | 12.90 | 1.131 | 3.32 | 308,418 | -9.38 | -77.97% |
| 5 Years | 11.48 | 17.20 | 1.131 | 3.55 | 299,561 | -8.83 | -76.92% |
LAVA Therapeutics NV Description
| LAVA Therapeutics NV is a biotechnology company. It is focused on transforming cancer treatment by developing a platform of novel bispecific antibodies designed to selectively induce gamma-delta T cell-mediated immunity against tumor cells. |
